X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52647) 52647
Book Review (8884) 8884
Newsletter (6512) 6512
Publication (4027) 4027
Newspaper Article (1638) 1638
Book / eBook (169) 169
Magazine Article (120) 120
Conference Proceeding (116) 116
Book Chapter (105) 105
Dissertation (70) 70
Web Resource (20) 20
Trade Publication Article (12) 12
Government Document (7) 7
Data Set (4) 4
Paper (3) 3
Presentation (3) 3
Journal / eJournal (2) 2
Report (2) 2
Reference (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48411) 48411
index medicus (47339) 47339
male (42803) 42803
prostate cancer (29706) 29706
aged (22328) 22328
middle aged (22214) 22214
cancer (20798) 20798
prostatic neoplasms - surgery (17436) 17436
oncology (17357) 17357
prostatic neoplasms - pathology (16145) 16145
urology & nephrology (13443) 13443
research (11738) 11738
prostatectomy (9930) 9930
care and treatment (9676) 9676
female (8978) 8978
surgery (8956) 8956
prostate (8118) 8118
adult (8109) 8109
prognosis (7836) 7836
prostate-cancer (7519) 7519
radical prostatectomy (7374) 7374
aged, 80 and over (7127) 7127
oncology, experimental (6656) 6656
prostate-specific antigen - blood (6345) 6345
abridged index medicus (6324) 6324
treatment outcome (6191) 6191
carcinoma (6064) 6064
neoplasm staging (6061) 6061
metastasis (5984) 5984
health aspects (5904) 5904
analysis (5708) 5708
radiotherapy (5517) 5517
risk factors (5390) 5390
retrospective studies (5316) 5316
urology (5200) 5200
prostatectomy - methods (5131) 5131
prostatic neoplasms - radiotherapy (5119) 5119
prostatic neoplasms - diagnosis (5117) 5117
animals (5010) 5010
tumors (4932) 4932
prostatic neoplasms - therapy (4928) 4928
diagnosis (4592) 4592
men (4551) 4551
prostatic neoplasms (4341) 4341
prostatic neoplasms - drug therapy (4317) 4317
prostatic neoplasms - blood (4293) 4293
follow-up studies (4209) 4209
biopsy (3998) 3998
cell line, tumor (3952) 3952
prostatic neoplasms - mortality (3745) 3745
expression (3731) 3731
breast-cancer (3654) 3654
prostate - pathology (3619) 3619
survival (3562) 3562
prostate-specific antigen (3492) 3492
radiology, nuclear medicine & medical imaging (3488) 3488
risk (3339) 3339
medicine & public health (3224) 3224
prostatic neoplasms - metabolism (3130) 3130
development and progression (3114) 3114
time factors (3060) 3060
article (3012) 3012
immunohistochemistry (3000) 3000
pathology (2991) 2991
reports (2880) 2880
prostatic neoplasms - genetics (2876) 2876
therapy (2850) 2850
mice (2759) 2759
patients (2758) 2758
adenocarcinoma (2752) 2752
mortality (2743) 2743
prospective studies (2731) 2731
genetic aspects (2701) 2701
cancer therapies (2684) 2684
progression (2674) 2674
adenocarcinoma - pathology (2667) 2667
disease progression (2659) 2659
medicine (2633) 2633
gene expression (2631) 2631
chemotherapy (2630) 2630
apoptosis (2624) 2624
quality of life (2584) 2584
breast cancer (2494) 2494
medical research (2479) 2479
adenocarcinoma - surgery (2452) 2452
disease-free survival (2420) 2420
radiation-therapy (2361) 2361
antigen (2360) 2360
cancer patients (2304) 2304
prostatectomy - adverse effects (2213) 2213
gene expression regulation, neoplastic (2201) 2201
research article (2194) 2194
neoplasm grading (2165) 2165
proteins (2160) 2160
quality-of-life (2160) 2160
outcomes (2148) 2148
survival rate (2142) 2142
predictive value of tests (2102) 2102
hematology, oncology and palliative medicine (2094) 2094
studies (2050) 2050
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (88) 88
Online Resources - Online (24) 24
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Markham Stouffville Hospital - Stacks (4) 4
Scarborough Hospital - General (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
Bridgepoint Health - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Credit Valley Hospital - Special Collections (1) 1
Gerstein Science - Withdrawn (1) 1
Lakeridge Health Sciences - Online (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57877) 57877
German (786) 786
French (761) 761
Japanese (483) 483
Spanish (435) 435
Russian (209) 209
Chinese (183) 183
Italian (160) 160
Polish (48) 48
Swedish (41) 41
Danish (38) 38
Dutch (29) 29
Hungarian (29) 29
Norwegian (28) 28
Czech (22) 22
Turkish (21) 21
Portuguese (20) 20
Hebrew (18) 18
Bulgarian (17) 17
Romanian (12) 12
Finnish (10) 10
Korean (9) 9
Croatian (6) 6
Serbian (5) 5
Afrikaans (2) 2
Arabic (2) 2
Greek (2) 2
Lithuanian (2) 2
Slovak (2) 2
Ukrainian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 15, pp. 1415 - 1424
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 15, pp. 1425 - 1437
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 06/2012, Volume 83, Issue 2, pp. 720 - 726
Purpose: To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children's... 
Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | 3RD INTERGROUP RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PEDIATRIC ONCOLOGY | VAGINAL RHABDOMYOSARCOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | Index Medicus | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 5, pp. 417 - 428
With a median follow-up of 13 years, a randomized comparison of radiotherapy with or without antiandrogen therapy in patients with a rising PSA level after... 
PHASE-III TRIAL | ANDROGEN DEPRIVATION | MEDICINE, GENERAL & INTERNAL | BICALUTAMIDE 150 MG | MONOTHERAPY | CARDIOVASCULAR MORTALITY | RADIOTHERAPY | RTOG | CASTRATION | CARCINOMA | MEDIAN FOLLOW-UP | Neoplasm Recurrence, Local - radiotherapy | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Radiotherapy - adverse effects | Neoplasm Recurrence, Local - mortality | Incidence | Neoplasm Metastasis | Aged, 80 and over | Prostatic Neoplasms - drug therapy | Gynecomastia - chemically induced | Double-Blind Method | Prostatic Neoplasms - surgery | Kaplan-Meier Estimate | Survival Rate | Combined Modality Therapy | Prostatic Neoplasms - mortality | Tosyl Compounds - adverse effects | Tosyl Compounds - therapeutic use | Androgen Antagonists - therapeutic use | Prostatectomy | Aged | Androgen Antagonists - adverse effects | Neoplasm Staging | Nitriles - adverse effects | Nitriles - therapeutic use | Usage | Care and treatment | Cancer patients | Antiandrogens | Radiotherapy | Prostate cancer | Health aspects | Gynecomastia | Tablets | Prostate-specific antigen | Oncology | Death | Radiation therapy | Cancer therapies | Survival | Prostate | Metastases | Index Medicus | Abridged Index Medicus
Journal Article